| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/23/2008 | EP1294382B1 7-hydroxyepiandrosterone having neuroprotective activity |
| 07/23/2008 | EP1272167B1 Ropinirole-containing hydrophilic/liphilic polymeric matrix dosage formulation |
| 07/23/2008 | EP1248841B1 Genes differentially expressed in breast cancer |
| 07/23/2008 | EP1246797B1 Cyclopentyl sulfonamide derivatives |
| 07/23/2008 | EP1242091B1 Use of pharmaceutical compositions comprising oxcarbazepine in the fasted state |
| 07/23/2008 | EP1239829B1 Devices for the delivery of drugs having antiprogestinic properties |
| 07/23/2008 | EP1218369B1 INHIBITORS OF c-JUN N-TERMINAL KINASES (JNK) AND OTHER PROTEIN KINASES |
| 07/23/2008 | EP1141241B1 Adult human astrocytes, preparation of the same, and uses thereof |
| 07/23/2008 | EP1126830B1 Pharmaceutical preparations for external use containing non-steroidal anti-inflammatory and analgesic agents |
| 07/23/2008 | EP1085876B1 Pharmaceutical composition with tumor necrosis factor a and 2-methoxyestrone-3-o-sulphamate for inhibition of estrone sulphatase |
| 07/23/2008 | EP1085862A4 Method of treating an autoimmune disorder |
| 07/23/2008 | EP1080092B1 Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation |
| 07/23/2008 | EP1073638B1 Heterocyclically substituted amides, their production and their use |
| 07/23/2008 | EP1071680B1 N,n-disubstituted amides that inhibit the binding of integrins to their receptors |
| 07/23/2008 | EP1047416B1 Pharmaceutical compositions comprising disulfiram for inhibiting angiogenesis |
| 07/23/2008 | EP1044199B1 Heterocyclic topoisomerase poisons |
| 07/23/2008 | EP0978284B1 Use of 15-keto-prostaglandin-e compounds as endothelin antagonists |
| 07/23/2008 | EP0957914B2 Formulation of 5-ht agonists |
| 07/23/2008 | EP0831769B2 Novel uses for thyroid hormones or thyroid hormone-like compounds |
| 07/23/2008 | EP0711158B2 Method of treating atherosclerosis or restenosis using microtubule stabilizing agent |
| 07/23/2008 | CN101228183A Method of purifying APO-2 ligand/TRAIL using crystallisation in the cold |
| 07/23/2008 | CN101228177A 3-ester prodrugs of estradiol |
| 07/23/2008 | CN101228175A Thiocolchicoside analogues with myorelaxant and anti-inflammatory activity |
| 07/23/2008 | CN101228172A 6,7-unsaturated-7-carbamoyl substituted morphinan derivative |
| 07/23/2008 | CN101228171A Macrolide conjugates of pyrrolizine and indolizine compounds as inhibitors of 5-lipooxygenase and cyclooxygenase |
| 07/23/2008 | CN101228169A Macrocyclic inhibitors of hepatitis c virus |
| 07/23/2008 | CN101228167A Pyrazolo[1,5-a]pyrimidin-7-yl amine derivatives as protein kinase inhibitors |
| 07/23/2008 | CN101228164A Pyrrolopyridine-based inhibitors of dipeptidyl peptidase IV and methods |
| 07/23/2008 | CN101228163A Aspartyl protease inhibitors |
| 07/23/2008 | CN101228162A 2-phenyl substituted imidazol [4,5b]pyridine/ pyrazine and purine derivatives as glucokinase modulators |
| 07/23/2008 | CN101228161A Pyrrolopyridines useful as inhibitors of protein kinase |
| 07/23/2008 | CN101228160A Azaindoles useful as inhibitors of protein kinases |
| 07/23/2008 | CN101228158A N-amide derivatives of 8-azabicyclo[3.2.1]oct-3-yl as ccr1 antagonists |
| 07/23/2008 | CN101228157A Amino acid salts of rosiglitazone |
| 07/23/2008 | CN101228155A Substituted oxadiazole derivatives as positive allosteric modulators of metabotropic glutamate receptors |
| 07/23/2008 | CN101228152A N-(heteroaryl)-1-heteroarylalkyl-1h-indole-2-carboxamide derivatives, preparation and therapeutic use thereof |
| 07/23/2008 | CN101228151A Salts of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidine-2-ylamino)-benzamide |
| 07/23/2008 | CN101228150A Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide |
| 07/23/2008 | CN101228149A Piperidinyl-substituted isoquinolone derivatives as rho-kinase inhibitors |
| 07/23/2008 | CN101228148A Thermally-processed cocoa products useful for vascular health improvement |
| 07/23/2008 | CN101228146A Benzofuran derivatives with therapeutic activities |
| 07/23/2008 | CN101228145A Organic compounds for the treatment of inflammatory or allergic conditions |
| 07/23/2008 | CN101228144A Activator for peroxisome proliferator-activated receptor |
| 07/23/2008 | CN101228143A Thiazole derivative |
| 07/23/2008 | CN101228139A Substituted benzo[d]isoxazol-3-yl amine compounds as analgesics |
| 07/23/2008 | CN101228137A Substituted triazole derivatives and their use as neurokinin 3 receptor antagonists |
| 07/23/2008 | CN101228136A 2-cyano-pyrimidines and -triazines as cysteine protease inhibitors |
| 07/23/2008 | CN101228135A Pyridazinone derivatives as thyroid hormone receptor agonists |
| 07/23/2008 | CN101228132A Cyclohexylamin isoquinolone derivatives as rho-kinase inhibitors |
| 07/23/2008 | CN101228131A 新的杂环亚基乙酰胺衍生物 New heterocyclic derivatives subunit acetamide |
| 07/23/2008 | CN101228130A Aryloxy quinolines and uses as 5-HT6 thereof |
| 07/23/2008 | CN101228129A Fluorinated pyridine N-oxide thrombin modulators and process for N-oxidation of nitrogen containing heteroaryls |
| 07/23/2008 | CN101228128A A process for the preparation of substituted phenyl ether compounds and rosiglitazone |
| 07/23/2008 | CN101228127A Novel piperidine derivative |
| 07/23/2008 | CN101228126A Process for the preparation of crystalline perindopril |
| 07/23/2008 | CN101228125A Cathepsin K inhibitors |
| 07/23/2008 | CN101228123A Novel 2-azetidinone derivatives and their use as cholesterol absorption inhibitors for the treatment of hyperlipidaemia |
| 07/23/2008 | CN101228121A Novel 8-sulfonyl-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5HT6 receptor |
| 07/23/2008 | CN101228120A HIV reverse transcriptase inhibitors |
| 07/23/2008 | CN101228119A Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5HT6 receptor |
| 07/23/2008 | CN101228114A Methods of purifying tigecycline |
| 07/23/2008 | CN101228113A Tigecycline and methods of preparing 9-aminominocycline |
| 07/23/2008 | CN101228112A Tigecycline and methods of preparation |
| 07/23/2008 | CN101228111A Tigecycline and methods of preparing 9-nitrominocycline |
| 07/23/2008 | CN101228110A 3-(2-(dimethylamino)methyl(cyclohex-1-yl))phenol maleate and its crystalline for |
| 07/23/2008 | CN101228108A Compounds for treatment of lipase-mediated diseases |
| 07/23/2008 | CN101227952A Emulsified skin external preparation and method for stabilizing the skin external preparation |
| 07/23/2008 | CN101227951A Emulsified skin external preparation and method for stabilizing the skin external preparation |
| 07/23/2008 | CN101227927A Combination of HMG-CoA reductase inhibitors and mTOR inhibitors |
| 07/23/2008 | CN101227916A Compositions and methods for the prevention and treatment of conditions associated with inflammation |
| 07/23/2008 | CN101227914A Particulate compsitions comprising alginate and/or alginic acid |
| 07/23/2008 | CN101227913A Self-gelling alginate systems and uses thereof |
| 07/23/2008 | CN101227912A Substituted phenylphosphates as mutual prodrugs of steroids and beta-agonists for the treatment of pulmonary inflammation and bronchoconstriction |
| 07/23/2008 | CN101227911A Use of spirostenols to treat mitochondrial disorders |
| 07/23/2008 | CN101227910A Use of delmopinol in the treatment of acne |
| 07/23/2008 | CN101227909A Combination comprising a pyrimidylaminobenzamides and a Flt-3 inhibitor for treating proliferative diseases |
| 07/23/2008 | CN101227908A Compositions for reducing the incidence of drug induced arrhythmia |
| 07/23/2008 | CN101227907A Quinine-containing controlled-release formulations |
| 07/23/2008 | CN101227906A Antiproliferative drug |
| 07/23/2008 | CN101227905A Process for preparing tiotropium salts, tiotropium salts as such and pharmaceutical compositions thereof |
| 07/23/2008 | CN101227904A Peritoneum protecting agent |
| 07/23/2008 | CN101227903A Novel 3-spirocyclic indolyl derivatives useful as ORL-1 receptor modulators |
| 07/23/2008 | CN101227902A New crystalline form of perindopril erbumine |
| 07/23/2008 | CN101227901A Anti-inflammatory agents |
| 07/23/2008 | CN101227900A Fish oil in stabilized form |
| 07/23/2008 | CN101227899A High drug load formulations and dosage forms |
| 07/23/2008 | CN101227898A Combination therapy with glatiramer acetate and riluzole |
| 07/23/2008 | CN101227896A Pharmaceutical formulation of nitrooxyderivatives of nsaids |
| 07/23/2008 | CN101227894A Rapidly disintegratable oral tablet |
| 07/23/2008 | CN101227893A Novel pharmaceutical modified release dosage form composition comprising cyclooxygenase enzyme inhibitor |
| 07/23/2008 | CN101227886A Gelatin-containing topical composition |
| 07/23/2008 | CN101227838A Process for preparing uronic acid oligosaccharides by extrusion |
| 07/23/2008 | CN101227836A Lycopene formulations for the treatment of atherosclerotic conditions |
| 07/23/2008 | CN101227823A Method for preparing concentration components of tetrahydro tetrahydroxy curcumin and tetrahydroxy curcumin from curcuma extractive |
| 07/23/2008 | CN101226199A Effect of N-methyl-D-asparagic acid acceptor in epilepsy generation |
| 07/23/2008 | CN101225424A Single-glucopyranoside of cyclomembranousol, preparation method, medicament combination and uses thereof |
| 07/23/2008 | CN101225390A MS gene order of diffuse large B cell lymphoma related antigen specific TCR V alpha 6 subfamily and uses thereof |
| 07/23/2008 | CN101225389A VR gene order of diffuse large B cell lymphoma related antigen specific TCR V alpha 23 subfamily and uses thereof |
| 07/23/2008 | CN101225388A MR gene order of diffuse large B cell lymphoma related antigen specific TCR V alpha 6 subfamily and uses thereof |
| 07/23/2008 | CN101225383A RNA interference sequence and recombinant interference plasmid of fucosyl transferase I and IV for suppressing synthesis of LeY carbohydrate antigen |